Patents-Review.com
🔗 Permalink
Assignee profile:

Galaxy Biotech, LLC

City:

Cupertino, California

Country:

United States

Published Applications:

21

Last publication date:

2021-08-05

Patent Grants:

13

Last grant date:

2024-02-06

Top Inventors for applications by Galaxy Biotech, LLC

These are the the leading inventors for applications assigned to Galaxy Biotech, LLC:

Recent patent applications by Galaxy Biotech, LLC

Galaxy Biotech, LLC based in Cupertino, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-08-05 ✅ Patent 11,891,446 granted on 2024-02-06
US20210238297A1
Chemistry; metallurgy

Highly potent antibodies binding to death receptor 5

 #2 | 2020-11-05
US20200347141A1
Chemistry; metallurgy

MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2

 #3 | 2019-05-23 ✅ Patent 10,689,448 granted on 2020-06-23
US20190153105A1
Chemistry; metallurgy

Monoclonal antibodies to fibroblast growth factor receptor 2

 #4 | 2019-02-28 ✅ Patent 10,941,204 granted on 2021-03-09
US20190062443A1
Chemistry; metallurgy

Highly potent antibodies binding to death receptor 4

 #5 | 2018-04-05 ✅ Patent 10,138,301 granted on 2018-11-27
US20180094063A1
Chemistry; metallurgy

Monoclonal antibodies to fibroblast growth factor receptor 2

 #6 | 2016-12-15 ✅ Patent 9,834,609 granted on 2017-12-05
US20160362496A1
Chemistry; metallurgy

Methods of detecting a tumor expressing fibroblast growth factor receptor 2

 #7 | 2015-04-23
US20150110788A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES WITH AN FGF2 BINDING DOMAIN

 #8 | 2014-07-10 ✅ Patent 9,382,324 granted on 2016-07-05
US20140193899A1
Chemistry; metallurgy

Monoclonal antibodies to fibroblast growth factor receptor 2

 #9 | 2013-08-15
US20130209482A1
Chemistry; metallurgy

MONOCLONAL ANTIBODIES TO BASIC FIBROBLAST GROWTH FACTOR

 #10 | 2012-05-31 ✅ Patent 8,603,987 granted on 2013-12-10
US20120134994A1
Chemistry; metallurgy

Monoclonal antibodies to fibroblast growth factor receptor 2

 #11 | 2012-03-15
US20120064066A1
Chemistry; metallurgy

Monoclonal Antibodies to Hepatocyte Growth Factor

 #12 | 2011-08-04
US20110189169A1
Human necessities

COMBINATION OF HGF INHIBITOR AND PTEN AGONIST TO TREAT CANCER

 #13 | 2010-11-04 ✅ Patent 8,628,778 granted on 2014-01-14
US20100278815A1
Chemistry; metallurgy

Humanized monoclonal antibodies to hepatocyte growth factor

 #14 | 2010-09-02
US20100221250A1
Chemistry; metallurgy

METHODS OF TREATING BRAIN TUMORS WITH ANTIBODIES

 #15 | 2010-08-05 ✅ Patent 8,101,723 granted on 2012-01-24
US20100196364A1
Chemistry; metallurgy

Monoclonal antibodies to fibroblast growth factor receptor 2

 #16 | 2009-12-10 ✅ Patent 8,101,725 granted on 2012-01-24
US20090304707A1
Chemistry; metallurgy

Monoclonal antibodies to basic fibroblast growth factor

 #17 | 2009-04-23
US20090104192A1
Chemistry; metallurgy

Monoclonal Antibodies to Hepatocyte Growth Factor

 #18 | 2008-01-24 ✅ Patent 7,632,926 granted on 2009-12-15
US20080019974A1
Chemistry; metallurgy

Humanized monoclonal antibodies to hepatocyte growth factor

 #19 | 2008-01-24 ✅ Patent 7,687,063 granted on 2010-03-30
US20080019966A1
Chemistry; metallurgy

Treating solid tumors with an antibody to hepatocyte growth factor

 #20 | 2007-07-12 ✅ Patent 7,494,650 granted on 2009-02-24
US20070160613A1
Chemistry; metallurgy

Monoclonal antibodies to hepatocyte growth factor

 #21 | 2007-02-15
US20070036797A1
Chemistry; metallurgy

Methods of treating brain tumors with antibodies

Also check out GALAXY BIOTECH, LLC's (Cupertino, United States) applicant profile with 6 patent applications submitted.

AssigneeID:

34780 ⎘